D. Overbosch

2.0k total citations
54 papers, 1.4k citations indexed

About

D. Overbosch is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Hepatology. According to data from OpenAlex, D. Overbosch has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 9 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in D. Overbosch's work include Travel-related health issues (19 papers), Malaria Research and Control (16 papers) and Mosquito-borne diseases and control (8 papers). D. Overbosch is often cited by papers focused on Travel-related health issues (19 papers), Malaria Research and Control (16 papers) and Mosquito-borne diseases and control (8 papers). D. Overbosch collaborates with scholars based in Netherlands, Germany and United Kingdom. D. Overbosch's co-authors include Perry J.J. van Genderen, Hans Dieter Nothdurft, Robert Steffen, Atti‐La Dahlgren, Pierre Van Damme, P D Clarke, Neil Roskell, Jeffrey D. Chulay, Kevin C. Kain and Robert J. Ligthelm and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

D. Overbosch

53 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D. Overbosch 882 223 194 169 121 54 1.4k
G Soula 693 0.8× 64 0.3× 112 0.6× 239 1.4× 88 0.7× 101 1.6k
Cho Naing 464 0.5× 126 0.6× 168 0.9× 226 1.3× 59 0.5× 67 1.2k
M. Mugambi 603 0.7× 65 0.3× 544 2.8× 134 0.8× 140 1.2× 25 1.3k
Hans O. Lobel 919 1.0× 90 0.4× 199 1.0× 112 0.7× 83 0.7× 39 1.3k
Éric Kendjo 1.1k 1.2× 58 0.3× 417 2.1× 194 1.1× 214 1.8× 56 1.5k
Gerard J. Casey 343 0.4× 73 0.3× 124 0.6× 73 0.4× 149 1.2× 26 934
Nicola Davies 1.7k 1.9× 53 0.2× 384 2.0× 154 0.9× 343 2.8× 83 2.2k
Udomsak Silachamroon 992 1.1× 30 0.1× 323 1.7× 397 2.3× 109 0.9× 78 1.6k
Lasse S Vestergaard 819 0.9× 26 0.1× 257 1.3× 314 1.9× 170 1.4× 56 1.5k
Prakaykaew Charunwatthana 962 1.1× 42 0.2× 165 0.9× 208 1.2× 253 2.1× 58 1.5k

Countries citing papers authored by D. Overbosch

Since Specialization
Citations

This map shows the geographic impact of D. Overbosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Overbosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Overbosch more than expected).

Fields of papers citing papers by D. Overbosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Overbosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Overbosch. The network helps show where D. Overbosch may publish in the future.

Co-authorship network of co-authors of D. Overbosch

This figure shows the co-authorship network connecting the top 25 collaborators of D. Overbosch. A scholar is included among the top collaborators of D. Overbosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Overbosch. D. Overbosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Genderen, Perry J.J. van, P. P. A. M. van Thiel, Paul Mulder, & D. Overbosch. (2013). Trends in the knowledge, attitudes and practices of travel risk groups toward prevention of hepatitis B: Results from the repeated cross-sectional Dutch Schiphol Airport Survey 2002–2009. Travel Medicine and Infectious Disease. 12(2). 149–158. 12 indexed citations
2.
3.
Driessen, Gertjan J., et al.. (2011). Travel‐Related Morbidity in Children: A Prospective Observational Study. Journal of Travel Medicine. 19(3). 144–149. 16 indexed citations
4.
Genderen, Perry J.J. van, et al.. (2011). Trends in Knowledge, Attitudes, and Practices of Travel Risk Groups Toward Prevention of Hepatitis A: Results From the Dutch Schiphol Airport Survey 2002 to 2009. Journal of Travel Medicine. 19(1). 35–43. 35 indexed citations
5.
Essen, Thomas A. van, Ruben S. van der Giessen, Sebastiaan K. E. Koekkoek, et al.. (2010). Anti-Malaria Drug Mefloquine Induces Motor Learning Deficits in Humans. Frontiers in Neuroscience. 4. 191–191. 16 indexed citations
6.
Genderen, Perry J.J. van, et al.. (2010). East and West, Home Is Best? A Questionnaire‐Based Survey on Mortality of Dutch Travelers Abroad. Journal of Travel Medicine. 18(2). 141–144. 6 indexed citations
7.
Genderen, Perry J.J. van, et al.. (2009). [Availability of antimalarial agents in Dutch hospitals].. PubMed. 153. A462–A462. 1 indexed citations
8.
Genderen, Perry J.J. van, et al.. (2006). Evaluation of Plasma Lactate as a Parameter for Disease Severity on Admission in Travelers with Plasmodium falciparum Malaria. Journal of Travel Medicine. 12(5). 261–264. 29 indexed citations
9.
Hoek, Anneke van den, et al.. (2006). The Quality of Travel Clinics in the Netherlands. Journal of Travel Medicine. 13(6). 356–360. 9 indexed citations
10.
Piersma, Djura, D. Overbosch, P. L. C. Petit, & Perry J.J. van Genderen. (2006). Protracted Fever After a Journey to India and Nepal: a Case of Persistent Salmonella paratyphi Infection. Journal of Travel Medicine. 11(4). 257–259. 2 indexed citations
11.
Overbosch, D.. (2006). Post-Marketing Surveillance: Adverse Events during Long-Term Use of Atovaquone/Proguanil for Travelers to Malaria-Endemic Countries. Journal of Travel Medicine. 10. S16–S20. 22 indexed citations
12.
Herck, Koen Van, Francesco Castelli, Jane N. Zuckerman, et al.. (2004). Knowledge, Attitudes and Practices in Travel-related Infectious Diseases: The European Airport Survey. Journal of Travel Medicine. 11(1). 3–8. 287 indexed citations
13.
Riemsdijk, Melanie M. van, Miriam Sturkenboom, J.H.M. Tulen, et al.. (2004). Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. British Journal of Clinical Pharmacology. 57(4). 506–512. 35 indexed citations
14.
Sturkenboom, Miriam, et al.. (2002). Neuropsychiatric events during prophylactic use of mefloquine before travelling. European Journal of Clinical Pharmacology. 58(6). 441–445. 38 indexed citations
15.
Overbosch, D., Herbert Schilthuis, Ulrich Bienzle, et al.. (2001). Atovaquone‐Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐Blind Study. Clinical Infectious Diseases. 33(7). 1015–1021. 176 indexed citations
16.
Eland, Ingo A., et al.. (1998). [Cholestatic hepatitis ascribed to the use of thiabendazole].. PubMed. 142(23). 1331–4. 4 indexed citations
17.
Overbosch, D., et al.. (1989). Inhibitory effects of cimetidine ketoconazole and miconazole on the metabolism of praziquantel.. PubMed. 57(2). 217–28. 10 indexed citations
18.
Hiemstra, Pieter S., et al.. (1989). Complete and partial deficiencies of complement factor D in a Dutch family.. Journal of Clinical Investigation. 84(6). 1957–1961. 67 indexed citations
19.
Overbosch, D., et al.. (1988). Familial Varices of the Colon. Endoscopy. 20(5). 270–271. 19 indexed citations
20.
Overbosch, D., et al.. (1987). Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. European Journal of Clinical Pharmacology. 33(3). 287–292. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Soula Breakdown of academic impact, for papers by Cho Naing Breakdown of academic impact, for papers by M. Mugambi Breakdown of academic impact, for papers by Hans O. Lobel Breakdown of academic impact, for papers by Éric Kendjo Breakdown of academic impact, for papers by Gerard J. Casey Breakdown of academic impact, for papers by Nicola Davies Breakdown of academic impact, for papers by Udomsak Silachamroon Breakdown of academic impact, for papers by Lasse S Vestergaard Breakdown of academic impact, for papers by Prakaykaew Charunwatthana
Rankless by CCL
2026